rs2234996
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000051.4(ATM):c.332-71A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0358 in 1,330,594 control chromosomes in the GnomAD database, including 1,091 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.026   (  64   hom.,  cov: 32) 
 Exomes 𝑓:  0.037   (  1027   hom.  ) 
Consequence
 ATM
NM_000051.4 intron
NM_000051.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.21  
Publications
9 publications found 
Genes affected
 ATM  (HGNC:795):  (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010] 
ATM Gene-Disease associations (from GenCC):
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- familial ovarian cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 11-108235599-A-G is Benign according to our data. Variant chr11-108235599-A-G is described in ClinVar as Benign. ClinVar VariationId is 1179574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0257 (3920/152360) while in subpopulation SAS AF = 0.0476 (230/4834). AF 95% confidence interval is 0.0425. There are 64 homozygotes in GnomAd4. There are 1835 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 64 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4 | c.332-71A>G | intron_variant | Intron 4 of 62 | ENST00000675843.1 | NP_000042.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0258  AC: 3924AN: 152242Hom.:  64  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3924
AN: 
152242
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0371  AC: 43661AN: 1178234Hom.:  1027   AF XY:  0.0372  AC XY: 22030AN XY: 592146 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
43661
AN: 
1178234
Hom.: 
 AF XY: 
AC XY: 
22030
AN XY: 
592146
show subpopulations 
African (AFR) 
 AF: 
AC: 
175
AN: 
26246
American (AMR) 
 AF: 
AC: 
661
AN: 
34762
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1991
AN: 
23880
East Asian (EAS) 
 AF: 
AC: 
5
AN: 
35122
South Asian (SAS) 
 AF: 
AC: 
3392
AN: 
74474
European-Finnish (FIN) 
 AF: 
AC: 
493
AN: 
44706
Middle Eastern (MID) 
 AF: 
AC: 
100
AN: 
3658
European-Non Finnish (NFE) 
 AF: 
AC: 
35105
AN: 
884990
Other (OTH) 
 AF: 
AC: 
1739
AN: 
50396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 2070 
 4140 
 6210 
 8280 
 10350 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1258 
 2516 
 3774 
 5032 
 6290 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0257  AC: 3920AN: 152360Hom.:  64  Cov.: 32 AF XY:  0.0246  AC XY: 1835AN XY: 74510 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3920
AN: 
152360
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1835
AN XY: 
74510
show subpopulations 
African (AFR) 
 AF: 
AC: 
322
AN: 
41594
American (AMR) 
 AF: 
AC: 
324
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
276
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
5190
South Asian (SAS) 
 AF: 
AC: 
230
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
84
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
5
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2574
AN: 
68024
Other (OTH) 
 AF: 
AC: 
66
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 203 
 406 
 608 
 811 
 1014 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 50 
 100 
 150 
 200 
 250 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
72
AN: 
3474
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.